Edition:
United States

Constellation Brands Inc (STZ.N)

STZ.N on New York Stock Exchange

160.53USD
15 Jan 2019
Change (% chg)

$-0.33 (-0.21%)
Prev Close
$160.86
Open
$160.75
Day's High
$160.77
Day's Low
$158.87
Volume
378,348
Avg. Vol
534,334
52-wk High
$236.62
52-wk Low
$150.37

Chart for

About

Constellation Brands, Inc. is an international beverage alcohol company. The Company is a producer and marketer of beer, wine and spirits with operations in the United States, Canada, Mexico, New Zealand and Italy. Its segments include Beer, Wine and Spirits, and Corporate Operations and Other. It is a multi-category supplier... (more)

Overall

Beta: 0.08
Market Cap(Mil.): $41,079.91
Shares Outstanding(Mil.): 195.60
Dividend: 0.52
Yield (%): 0.99

Financials

  STZ.N Industry Sector
P/E (TTM): 26.88 30.69 40.45
EPS (TTM): 7.82 -- --
ROI: 10.81 7.17 61.28
ROE: 23.30 12.73 72.73

Constellation cuts forecast as pot investment, wine business weigh

Corona-maker Constellation Brands Inc cut its 2019 profit outlook on Wednesday, citing weakness in wine and spirits sales and costs related to its investment in a Canadian pot producer, sending its shares down to a near two-year low. | Video

Jan 09 2019

UPDATE 3-Constellation cuts forecast as pot investment, wine business weigh

Jan 9 Corona-maker Constellation Brands Inc cut its 2019 profit outlook on Wednesday, citing weakness in wine and spirits sales and costs related to its investment in a Canadian pot producer, sending its shares down to a near two-year low.

Jan 09 2019

Constellation Brands profit falls 38 pct, cuts full-year outlook

Jan 9 Constellation Brands Inc reported on Wednesday a 38.5 percent drop in third-quarter profit, burdened by higher freight and input costs, and cut its adjusted profit outlook for fiscal 2019.

Jan 09 2019

Canadian M&A seen rising after hitting 12-year high in 2018

TORONTO Canadian merger-and-acquisition activity is expected to strengthen in 2019 as a slump in oil prices could fuel consolidation among energy companies and cannabis deals gain momentum, M&A advisers said.

Jan 04 2019

Canadian M&A seen rising after hitting 12-year high in 2018

TORONTO, Jan 4 Canadian merger-and-acquisition activity is expected to strengthen in 2019 as a slump in oil prices could fuel consolidation among energy companies and cannabis deals gain momentum, M&A advisers said.

Jan 04 2019

Breakingviews - Weed, China, guns and money lead most-read stories

(Reuters Breakingviews) - Reuters Breakingviews predicted 2018 would bring “Froth and Frustration.” And that’s just what investors got as stocks hit new highs during the year before retreating toward bear-market territory as the year came to an end.

Dec 27 2018

Breakingviews - Big Weed is better off without Big Tobacco embrace

NEW YORK (Reuters Breakingviews) - Big ambitions require investment, but not all infusions of capital are equal. Cronos, the Canadian pot producer, is in early talks with Marlboro maker Altria, Reuters reported on Monday. An association with a huge tobacco company isn’t exactly what this nascent industry needs.

Dec 03 2018

Citron's Left calls Tilray surge its 'worst day ever' in market

NEW YORK Andrew Left, one of Wall Street's most prominent short-sellers, said Tilray Inc gave his firm its "worst day ever in the market" two months ago when its shares almost doubled in one session, but he remains bearish on the Canadian cannabis company.

Nov 12 2018

REUTERS SUMMIT-Citron's Left calls Tilray surge its 'worst day ever' in market

NEW YORK, Nov 12 Andrew Left, one of Wall Street's most prominent short-sellers, said Tilray Inc gave his firm its "worst day ever in the market" two months ago when its shares almost doubled in one session, but he remains bearish on the Canadian cannabis company.

Nov 12 2018

REUTERS SUMMIT-Citron's Left bearish on Canadian cannabis industry

NEW YORK, Nov 12 Citron Research's Andrew Left, one of the most prominent short-sellers on Wall Street, is bearish on Canadian cannabis producers such as Tilray Inc , despite big gains last week, as he expects them to be overtaken by U.S. rivals once recreational marijuana is legalized in the United States, he told the Reuters Global Investment Outlook Summit in New York on Monday.

Nov 12 2018

Earnings vs. Estimates